Palatin Technologies
J. Don Wang, PhD, serves as Vice President of Product Development. He is responsible for all chemistry, manufacturing, and control (CMC) activities including managing CDMOs and CMOs for drug substance and drug product formulation, analytical, manufacturing process, and supply chain development.
This person is not in any offices
Palatin Technologies
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system.